Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: April 4, 2012
Last updated: May 22, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)